Eli Lilly
Use attributes for filter ! | |
Gender | Male |
---|---|
Death | 47 years ago |
Date of birth | April 1,1885 |
Zodiac sign | Aries |
Born | Indianapolis |
Indiana | |
United States | |
Date of died | January 24,1977 |
Died | Indianapolis |
Indiana | |
United States | |
Known for | Eli Lilly and Company |
Philanthropy | |
Children | Josiah K. Lilly Sr. |
Spouse | Maria Cynthia Sloan |
Emily Lemen | |
Education | Saint Joseph's University - University City Campus |
Place of burial | Crown Hill Funeral Home and Cemetery, Indianapolis, Indiana, United States |
Grandchildren | Eli Lilly |
Josiah K. Lilly Jr. | |
Books | Prehistoric Antiquities of Indiana: A Description of the Notable Earthworks, Mounds, Implements and Ceremonial Objects Left in Indiana by Our Predecessors, Together with Some Information as to Their Origin and Antiquity, and the Prehistory of Indiana |
Founded | Lilly Endowment |
Indiana Landmarks | |
Parents | Josiah K. Lilly Sr. |
Grandparents | Eli Lilly |
Date of Reg. | |
Date of Upd. | |
ID | 2280782 |
Eli Lilly Life story
Eli Lilly, sometimes referred to as Eli Lilly Jr. to distinguish him from his grandfather of the same name, was an American pharmaceutical industrialist and philanthropist from Indianapolis, Indiana, United States.
Mounjaro obesity jab authorised in UK
... Manufacturer Eli Lilly has been asked to submit more data for the committee to review...
Drug donanemab seen as turning point in dementia fight
... " Donanemab, made by Eli Lilly, works in the same way as lecanemab - developed by companies Eisai and Biogen - when it was proven to slow the disease...
NHS watchdog rejects Mounjaro fat loss jab for diabetes
... " Manufacturer Eli Lilly has been asked to submit more data for the committee to look at ahead of its next meeting...
New Alzheimer's drug slows disease by a third
... The company Eli Lilly has reported its drug - donanemab - slows the pace of Alzheimer s by about a third...
Twitter's paid blue tick re-launches after pause
... In one instance, a user claiming to be the US pharmaceutical firm Eli Lilly tweeted " insulin is free" causing the real firm s share price to tumble - however, Ely Lilly has since agreed that insulin prices could indeed be lower...
Twitter chaos after wave of blue tick impersonations
... One of the most disruptive accounts impersonated US pharmaceutical company Eli Lilly, and declared " insulin is free now"...
NHS watchdog rejects Mounjaro fat loss jab for diabetes
By Michelle RobertsDigital health editor
A new diabetes Medicine dubbed the " King Kong" of weight loss jabs cannot be recommended on the NHS yet because the cost for benefit may not be justified, a spending watchdog says.
The National Institute for Health and Care Excellence (NICE) says it needs more evidence on Mounjaro, even though it recently approved a similar weekly injection called Wegovy.
Both drugs blunt appetite, so users feel full and eat less.
They also help manage blood glucose.
Social Media posts about people, often celebrities, shedding large amounts of weight has led to big demand for these types of treatment.
There have been ongoing global shortages of another injection for type 2 diabetes, called Ozempic, That Some People have been buying off-label as a weight loss aid. The pre-filled pens contain a lower dose of of the same Medicine - semaglutide - That is in Wegovy.
The Draft guidelines from NICE say it is yet to be established if Mounjaro, also known as tirzepatide, represents good value for money, alongside diet and exercise, for adults with type 2 diabetes and a high body mass index.
The NHS price of the pre-filled pens has not been made public because of commercial sensitivities.
Helen Knight, from NICE, said: " Type 2 diabetes is becoming more prevalent In Society , so new treatment options are needed to help people with it to control their blood-glucose levels.
" Our committee can see The Promise in tirzepatide, but it requires more evidence to be able to evaluate both its clinical, and cost, effectiveness. "
Manufacturer Eli Lilly has been asked to submit more data for The Committee to look at ahead of its next meeting.
This recommendation in England is not intended to affect treatment with tirzepatide That was started in the NHS before this guidance was published, says NICE.
People having treatment outside this recommendation may continue without change, until they and their NHS clinician consider it appropriate to stop.
Wegovy (semaglutide), meanwhile, for use by the NHS in England for adults with at least one obesity-related health problem, which can include type 2 diabetes.
Stocks are Not Yet available, but the Prime Minister has said, as well as specialist weight management clinics.
Rishi Sunak said it could be a " game-changer" as he announced a £40m pilot scheme to increase access to the drug.
Related TopicsSource of news: bbc.com